🔗 Share this article

A shadow economy for unlicensed slimming drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.

Experimental Treatment Gaining Traction Via Social Media

The experimental drug, which is still in research studies, is being promoted by online personalities for its alleged weight-reducing properties. Followers are encouraged to contact these accounts privately for source information, while also obtaining discount codes.

Active Commerce on Messaging Platforms

Additionally, a flourishing market exists on messaging services, where communities with numerous of members share comparison photos, injection guides and assertions of rapid UK delivery. Vendors promote the substance there before redirecting buyers to WhatsApp for transactions.

Learning About Retatrutide

This medication is an investigational injection created by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Experts Voice Worries

However, doctors and pharmacists have warned that the sale of what is still an unapproved medication in the UK is a cause for concern and could lead to users injecting products of uncertain source.

Some professionals said the popularity for the experimental drug could be connected to the rising price of licensed weight loss treatments such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the British medical regulations.

Some content creators attempt to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still breach pharmaceutical, marketing, and customer regulations, risking fines, legal action or imprisonment.

Service Response and Content Elimination

Based on TikTok, the platform has removed problematic content and prohibited associated keywords and search suggestions. The company said it was committed to maintaining the platform secure and investing in strengthening compliance measures.

Digital Marketplace Operations

Research also discovered communities with up to 9,000 participants selling the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Typing “retatrutide” instantly brings up groups with thousands of members, filled with photos of slimming results, positive testimonials and step-by-step guides for preparing or administering at home.

After moments of joining one community, a vendor posted WhatsApp details, where most transactions occur. The seller sent an instruction manual and guaranteed shipping within two days. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one inquired about body mass, medical conditions or past usage.

Item Information and Costs

Inside these groups, posts show dark colored packages with postal service labels, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with purified liquid, or pre-filled pens typically priced at £160 for 20mg. When asked how long a pen should be used, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for the messaging service stated it regularly moderated harmful content on its platform including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering substances they can’t verify. Even if the science behind this drug is valid, these digital products may not contain what they advertise,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to current price rises for approved slimming medications such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit injections are highly risky. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she explained.

Her staff has previously encountered patients injured by self-injection from unconfirmed sources. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your health,” stated Wyllie. “These materials could be impure or improperly measured.”

Producer Statement

A spokesperson from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a company investigational substance not yet authorized … may subject users to potentially significant health risks”.